The Good and the Bad Some will see this pp before results as an indication results are not good. However its not likely the company knows the results until this Friday. So therefore the pp is prudent and not large considering the massive upside potential here.
There are other examples of repurposed drugs that have gone on to be blockbusters in their new indications. Most of you know blockbuster refers to a drug with sales in excess of $1 Billion annually. So next to this type of upside a $2.7 million raise from just over 10 million shares is not a big deal at all. Don't forget we also raised a few million recently with the exercise of outstanding warrants . The company has some cash and that is not a negative.
From Aug.12, 2020 news release:
the Company is betting that this quiet and unassuming safe generic drug may soon become a global blockbuster. The Company is claiming it has filed new patents globally for Ifenprodil for the treatment of respiratory diseases. Algernon has advised that they are following the same re-purposed drug business model as Biogen with their re-purposed drug Tecfidera and Celgene’s Thalidomide, both billion dollar blockbuster drugs in their own right.
I googled Tecfidera and found they did over $1 billion in sales from a single quarter. Yes in just 3 months thats what a repurposed drug did in sales.
Hello is anyone awake out there? We are in the largest medical crisis of our lifetimes and here this little penny stock may well have a repurposed drug that kicks butt where it needs to be kicked. If so, this has blockbuster written all over it. Massive upside potential from this tiny cap we are starting with.
We will know a lot more next week. Don't forget the two videos regarding the phase 2 trial which both sound extremely positive.